Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.11851/10367
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKızıltoprak, Hasan-
dc.contributor.authorÖzkoyuncu Kocabaş, Dilara-
dc.contributor.authorAksoy Aydemir, Gözde-
dc.contributor.authorKalınlı, Emine Merve-
dc.contributor.authorAydemir, Emre-
dc.contributor.authorÖren, Burak-
dc.date.accessioned2023-04-16T10:01:18Z-
dc.date.available2023-04-16T10:01:18Z-
dc.date.issued2022-
dc.identifier.issn0191-3913-
dc.identifier.issn1938-2405-
dc.identifier.urihttps://doi.org/10.3928/01913913-20221026-01-
dc.identifier.urihttps://hdl.handle.net/20.500.11851/10367-
dc.descriptionArticle; Early Accessen_US
dc.description.abstractPurpose:To investigate choroidal vascularity in children with attention-deficit/hyperactivity disorder (ADHD) who were not receiving therapy, children with ADHD who were regularly taking methylphenidate (MPH), and healthy controls.Methods: The study included three groups: patients with newly diagnosed ADHD without treatment, patients diagnosed as having ADHD who were already being treated with oral MPH, and controls. Both choroidal vascularity index (CVI) and choroidal thickness were measured using an enhanced-depth imaging mode of spectral-domain optical coherence tomography (EDIOCT) (Spectralis; Heidelberg Engineering GmbH).Results: There was a significant difference in CVI and stromal area between groups. Post-hoc univariate analysis showed that CVI was significantly lower in patients with ADHD treated with MPH compared with the other groups (P < .001, for each); however, there was no difference between the treatment-free ADHD group and controls (P = .305). In contrast, stromal area was significantly higher in patients with ADHD treated with MPH than the other groups (P < .001, for each group). The correlation of CVI with MPH treatment duration in patients with ADHD treated with MPH showed a significant, moderate negative correlation (P = .01, r = - 0.66).Conclusions: CVI is reduced in patients with ADHD treated with MPH, and the decrease in CVI becomes significant with increasing duration of MPH treatment. This result reflects an indirect effect of MPH treatment on choroidal vascular structures.[J Pediatr Ophthalmol Strabismus. 20XX;X(X):XX-XX.]en_US
dc.language.isoenen_US
dc.publisherSlack Incen_US
dc.relation.ispartofJournal of Pediatric Ophthalmology & Strabismusen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDeficit Hyperactivity Disorderen_US
dc.subjectChildrenen_US
dc.subjectAdolescentsen_US
dc.subjectThicknessen_US
dc.subjectLayeren_US
dc.titleChoroidal Vascular Index in Patients With Attention-Deficit/Hyperactivity Disorder and Methylphenidateen_US
dc.typeArticleen_US
dc.departmentTOBB ETÜen_US
dc.identifier.wosWOS:000904855200001en_US
dc.identifier.scopus2-s2.0-85178499888en_US
dc.institutionauthor-
dc.identifier.pmid36546779en_US
dc.identifier.doi10.3928/01913913-20221026-01-
dc.authorwosidaksoy aydemir, gozde/HOH-7782-2023-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopusqualityQ3-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairetypeArticle-
item.cerifentitytypePublications-
item.languageiso639-1en-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

Page view(s)

18
checked on Mar 25, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.